Press Releases
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the U.S. FDA granted Emergency Use Authorization (EUA) for a rapid,...
Drug Research
Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market
With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal...
Clinical Trials
QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19
QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment...
Drug Research
CIRION BioPharma Research Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing Services
CIRION Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced that the company is now offering new...
News
Ege University improves patient access to leading edge healthcare treatment options by joining Clinerion Patient Network Explorer platform.
Ege University Medical Faculty Hospital brings its patients earlier access to leading-edge treatments and medications by joining the international hospital network on Clinerion’s Patient...
Clinical Trials
Zydus vaccine for COVID-19 (ZyCoV-D) successfully completes preclinical development and receives permission to initiate human clinical trials
Zydus an innovation-driven, global pharmaceutical company, announced that it's plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its Vaccine Technology Centre in...
Drug Research
BioInvent extends research collaboration and license agreement with Pfizer Inc
BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read